Stake Announced
Novo Nordisk stake in Orbis Medicines
Announced Sep 2026
Advisers
Orbis Medicines
Target
Not disclosed
- Target
- Orbis Medicines
- Acquirer
- Novo Nordisk
- Target based in
- Denmark (unverified)
- Buyer based in
- Denmark
- Structure
- Minority stake
- Sector
- Biotech
- Tags
- Biotech, Drug Development
Similar deals
- Leyden Labs acquisition of RIGImmune Sep 2026 · Biotech
- GSK acquisition of trispecific T cell-engager (TCE) asset Sep 2026 · US$750m · Biotech
- Eli Lilly and Company acquisition of Merida Biosciences Aug 2026 · US$2.9bn · Biotech
- Werewolf Therapeutics and Ambros Therapeutics merger Aug 2026 · US$500m · Biotech
- BioMarin Pharmaceutical acquisition of Alesta Therapeutics Aug 2026 · US$275m · Biotech
